Exogenous neural stem cell transplantation for cerebral ischemia

Area of Science:

• Neuroscience
• Regenerative Medicine
• Neurology

Background:

• Cerebral ischemic injury, a primary cause of stroke (70-80% incidence), leads to severe neurological deficits.
• Current treatments like tissue-type plasminogen activator have a narrow therapeutic window.
• Paralysis, sensory loss, and cognitive impairments are common sequelae of ischemic stroke.

Purpose of the Study:

• To review the therapeutic potential of neural stem cell transplantation for ischemic stroke.
• To explore the mechanisms by which neural stem cells promote nervous system repair and functional recovery.

Main Methods:

• Systematic review of research on neural stem cell transplantation in ischemic stroke models and clinical studies.
• Analysis of studies investigating neural stem cell differentiation, migration, and integration into damaged brain tissue.
• Examination of research on the paracrine effects and immunomodulatory roles of transplanted neural stem cells.

Main Results:

• Neural stem cells demonstrate neuroprotective effects and promote neurogenesis and angiogenesis in stroke-affected brain regions.
• Transplanted cells can differentiate into neural lineages, replacing damaged neurons and glial cells.
• Neural stem cells modulate the inflammatory response and reduce secondary brain damage post-stroke.

Conclusions:

• Neural stem cell transplantation is a promising therapeutic strategy for ischemic stroke, addressing limitations of current treatments.
• The regenerative and reparative mechanisms of neural stem cells offer potential for functional recovery in stroke patients.
• Further research is warranted to optimize delivery methods, cell types, and long-term efficacy for clinical application.